CORT - Corcept Therapeutics GAAP EPS of $0.25 beats by $0.10 revenue of $117.7M beats by $8.1M
2023-08-02 16:52:56 ET
- Corcept Therapeutics press release ( NASDAQ: CORT ): Q2 GAAP EPS of $0.25 beats by $0.10 .
- Revenue of $117.7M (+13.8% Y/Y) beats by $8.1M .
- Increase in 2023 revenue guidance to $455 - $470 million, from $435 - $455 million
For further details see:
Corcept Therapeutics GAAP EPS of $0.25 beats by $0.10, revenue of $117.7M beats by $8.1M